Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Yara Banz"'
Autor:
Michèle Hoffmann, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Ulrike Bacher, Thomas Pabst
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 2067-2075 (2024)
Donor cell leukemia (DCL) is a rare complication after allogeneic hematopoietic stem cell transplantation (HSCT) accounting for 0.1% of relapses and presenting as secondary leukemia of donor origin. Distinct in phenotype and cytogenetics from the ori
Externí odkaz:
https://doaj.org/article/b7cce01b312e4f65b8657380b2efa76d
Autor:
Isabel Arenas Hoyos, Anja Helmer, Anaïs Yerly, Ioana Lese, Stefanie Hirsiger, Lei Zhang, Daniela Casoni, Luisana Garcia, MariaFrancesca Petrucci, Sabine E. Hammer, Tereza Duckova, Yara Banz, Matteo Montani, Mihai Constantinescu, Esther Vögelin, Gregor Bordon, Simone Aleandri, Jean-Christophe Prost, Adriano Taddeo, Paola Luciani, Robert Rieben, Nicoletta Sorvillo, Radu Olariu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe standard treatment for preventing rejection in vascularized composite allotransplantation (VCA) currently relies on systemic immunosuppression, which exposes the host to well-known side effects. Locally administered immunosuppression
Externí odkaz:
https://doaj.org/article/3e407b5b4cfb452a91c1f1944aded4ad
Autor:
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Ulrike Bacher, Thomas Pabst
Publikováno v:
Current Oncology, Vol 30, Iss 12, Pp 10463-10476 (2023)
Chimeric antigen receptor T (CAR T)-cell therapy has become a standard treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL). Mutations in the PPM1D gene, a frequent driver alteration in clonal hematopoie
Externí odkaz:
https://doaj.org/article/2c44c5cc352f41dea481d90c3b1060c3
Autor:
Lei Zhang, Isabel Arenas Hoyos, Anja Helmer, Yara Banz, Cédric Zubler, Ioana Lese, Stefanie Hirsiger, Mihai Constantinescu, Robert Rieben, Mitra Gultom, Radu Olariu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundVascularized composite allotransplantation (VCA) offers the potential for a biological, functional reconstruction in individuals with limb loss or facial disfigurement. Yet, it faces substantial challenges due to heightened immune rejection
Externí odkaz:
https://doaj.org/article/9ff07474364446e08b2ca0c1527c091d
Autor:
Tatiana Wojtovicova, Drahomir Aujesky, Stephan Jakob, Nicolas Bonadies, Hansjakob Furrer, Urban Novak, Thomas Pabst, Britta Maurer, Burkhard Möller, Roman Christian Abegglen, Aristomenis Exadaktylos, Annalisa Berzigotti, Yara Banz, Vera Ulrike Bacher, Sacha S. Zeerleder, Joerg C. Schefold, André Tichelli, Anne Angelillo-Scherrer, Alicia Rovó
Publikováno v:
HemaSphere, Vol 7, p e39708d4 (2023)
Externí odkaz:
https://doaj.org/article/c3ef9c390c7e453d9c3914d57ac38e31
Autor:
Ekaterina Rebmann Chigrinova, Naomi A. Porret, Martin Andres, Gertrud Wiedemann, Yara Banz, Myriam Legros, Matthias Pollak, Elisabeth Oppliger Leibundgut, Thomas Pabst, Ulrike Bacher
Publikováno v:
BMC Medical Genomics, Vol 15, Iss 1, Pp 1-9 (2022)
Abstract Background Next-generation sequencing (NGS) detects somatic mutations in a high proportion of plasma cell dyscrasias (PCD), but is currently not integrated into diagnostic routine. We correlated NGS data with degree of bone marrow (BM) invol
Externí odkaz:
https://doaj.org/article/08f55c3527b347d18880b9d7c2848afa
Autor:
Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri Taleghani, Urban Novak, Thomas Pabst
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Introduction: Autologous stem cell transplantation (ASCT) following high-dose chemotherapy is applied for patients with relapsed/refractory (r/r) DLBCL. However, prognosis of relapsing DLBCL post-ASCT remained poor until the availability of CAR-T cel
Externí odkaz:
https://doaj.org/article/601b18a0eecb4fb3aca4d1502d36b86d
Autor:
Evgenii Shumilov, Paolo Mazzeo, Martin S. Zinkernagel, Myriam Legros, Naomi Porret, Lorenz Romagna, Detlef Haase, Georg Lenz, Urban Novak, Yara Banz, Thomas Pabst, Ulrike Bacher
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 766-776 (2022)
Background: Intraocular lymphoma (IOL) presents a real challenge in daily diagnostics. Cyto- and/or histopathology of vitreous body represent the diagnostic cornerstones. Yet, false negative results remain common. Therefore, we analyzed the diagnosti
Externí odkaz:
https://doaj.org/article/ddb345b0544b4e509dcd48373ac70191
Autor:
Fabrizio Huwyler, Rebekka Kunz, Ulrike Bacher, Michèle Hoffmann, Urban Novak, Michael Daskalakis, Yara Banz, Thomas Pabst
Publikováno v:
Cancers, Vol 15, Iss 7, p 2091 (2023)
(1) Background: First-line therapy in fit MCL patients may comprise high-dose chemotherapy (HDCT) with autologous transplantation to consolidate remission before maintenance treatment. However, optimization of HDCT is an unmet clinical need given the
Externí odkaz:
https://doaj.org/article/a82d8abe858b4d23aaed22ee4918a9b6
Autor:
Jeanne Bohler, Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Publikováno v:
Cancers, Vol 15, Iss 1, p 44 (2022)
In patients with relapsed/refractory Burkitt lymphoma (r/r BL), overall survival (OS) is poor, and effective therapies and evidence for the best therapy are lacking. The monoclonal antibody blinatumomab may represent a novel option. However, only lim
Externí odkaz:
https://doaj.org/article/a37e810348ec416eafc10fe46e2c8dd3